SCHEMBL3763570

SCHEMBL3763570

[CH2]Cc1ccc(C)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ KDM1A O60341 1/20 0.41
▸ HPGD P15428 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CCR2 P41597 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ AGTR1 P30556 1/20 0.37
▸ RAPGEF4 Q8WZA2 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3753927 0.82 S1PR1 (0.38) RAPGEF4IDO1NPC1SMN1; SMN2MEN1
SCHEMBL12107538 0.81 CYP3A4 (0.54) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL30031076 0.79 CYP3A4 (0.48) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL4026046 0.79 CYP3A4 (0.48) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL1755262 0.79 MAPT (0.49) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL93982 0.78 IDO1 (0.58) HTTIDO1NPC1RAB9ASMN1; SMN2
SCHEMBL722216 0.78 ALDH1A1 (0.40) CYP3A4ALDH1A1HTTL3MBTL1GAA
SCHEMBL9073026 0.77 CYP3A4 (0.46) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL11086985 0.77 IDO1 (0.64) CYP3A4ALDH1A1NPSR1KDM1AHPGD
SCHEMBL109221 0.77 CYP3A4 (0.52) CYP3A4ALDH1A1NPSR1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 — — EP disclosed
US-8426631-B2 Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same BASF SE (DE) 2013-04-23 — — US disclosed
US-20100304966-A1 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same BASF SE (DE) 2010-12-02 — — US disclosed
US-20090082394-A1 Tetrahydroisoquinoline Derivatives to Enhance Memory Function ACTELION PHARMACEUTICALS, LTD. (CH) 2009-03-26 — — US disclosed
EP-1998774-A1 TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION Actelion Pharmaceuticals Ltd. (CH) 2008-12-10 — — EP disclosed
WO-2007105177-A1 TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION ACTELION PHARMACEUTICALS LTD (CH) 2007-09-20 — — WO disclosed
US-4108982-A DIURETICS, HYPOTENSIVE AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1978-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082394-A1 Tetrahydroisoquinoline Derivatives to Enhance Memory Function GRIN2A, BDNF, GRIN2C CYP3A4 2879/4885ALDH1A1 2981/4885NPSR1 566/4885
US-20100304966-A1 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same CYP51A1, ERG28, CAT CYP3A4 55/4885ALDH1A1 651/4885NPSR1 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback